期刊文献+

急性非ST段抬高性心肌梗死患者早期N-末端脑钠肽前体水平对其预后的影响 被引量:1

下载PDF
导出
摘要 目的探讨急性非ST段抬高性心肌梗死(NSTEMI)患者住院早期血浆N-末端脑钠肽前体(NT-proBNP)对其预后的影响。方法采用酶联免疫吸附法(ELISA)测定127例AMI患者住院早期血浆NT-proBNP水平,并与左室射血分数(LVEF)、1年主要不良心脏事件(MACE)对比分析。结果 NSTEMI早期患者血浆NT-proBNP水平为(375.3±98.4)pg/ml,与LVEF呈负相关(r=-0.447,P<0.01)。1年期发生MACE患者的血浆NT-proBNP水平明显高于未发生MACE者(463.4±58.3pg/mlvs246.6±103.9pg/ml,P<0.01)。结论 AMI患者血浆NT-proBNP水平与LVEF呈负相关。检测血浆NT-proBNP水平可预测AMI患者梗死面积、心功能及心血管事件的发生情况。
出处 《中国实用医药》 2012年第20期81-81,共1页 China Practical Medicine
  • 相关文献

参考文献3

二级参考文献5

  • 1Wong G C, Frisch D, Murphy S A, et al. Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction [J]. Am J Cardiol, 2003,91 (10) : 1163-1167.
  • 2Furchgott R F, Zawadski J V. The obligatory role of endothelial ceils in the relaxation of arterial smooth muscle ceils by acetycholine [J]. Nature, 1980, 288(5789) :373-376.
  • 3Amr E A, Judith A B, Stacy D B, et al. Acute Angiographic Analysis of Non-ST-Segment Elevation Acute Myocardial Infarction [ J ]. Am J Cardiol, 2004,94 ( 7 ) : 907-909.
  • 4Sabia P J, Powers E R, Ragosta M, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction [J] . N Engl J Med, 1992,327(26) : 1852.
  • 5Terkelsen C J, Lassen J F, Norgaard B L, et al. Mortality rates in patients with ST-elevation vs non-ST-elevation acute myocardial infarction: observations from an unselected cohort [J]. European Heart Journal, 2005, 26( 1 ) : 18-26.

共引文献10

同被引文献26

  • 1Bansal S, Ridker PM. Comparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C-reactive protein [J]. Am J Cardiol, 2007 ,99( 11) : 1500-1503.
  • 2Alamagor M. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease [J] . Am Heart J,2003,145(2) :248-253.
  • 3Pearson TA,Mensah GA,Alexander RW,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation,2003, 107 (3) :499-511.
  • 4Jiang 5. Bao Y , Hou X, et al. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population [J]. Am J Cardiol, 2009 , 103 (12) : 1727 -1731.
  • 5Wensley F ,Gao P ,Burgess S,et al. Associatoin between C reactive protein and coronary heart disease: mendelian randomization analysis based on individual participant data [J]. BMJ, 2011 (342) :d548.
  • 6Danesh J, Pepys MB. C-reactive protein and coronary disease: is there a causal link? [J]. Circulation,2009,120(21) :2036-2039.
  • 7Kelly R, Struthers AD. Are natiuretic peptide clinically useful as markers of heart failure? [J] . Ann Clin Biochem, 2001 ,38 (2) : 94-102.
  • 8Dickstein K,Cohen-Solal A, Filippatos G,et al. ESC guidelines for the diagnosis and treatment of acute chronic heart failure 2008 : the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [J]. Eur J Heart Fail,2008,10(10) :933-989.
  • 9Nicholls MG, Frampton CM, Yandle TG, et al. BNP: not just for failure [J]. Heart ,2008,94(1) :6-7.
  • 10Eren NK, Ertas F, Yukesk U. Additive prognostic value of NTproBNP over TIMI risk scorein intermediate-risk patients with acute coronary syndrome [J] . Arch Turk Soc Cardiol, 2009 ,37 ( 1 ) : 1-8.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部